Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Lupus Erythematosus”

Showing 20 of 0 results

Not applicableStudy completedNCT01516788
What this trial is testing

Photoprovocation Testing in Subjects With Cutaneous Lupus

Who this might be right for
Lupus ErythematosusPhotosensitivity Conditions
University of Pennsylvania 19
Large-scale testing (Phase 3)UnknownNCT03178188
What this trial is testing

Efficacy of 595 nm Pulsed-dye Laser in Treatment of Discoid Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Discoid
Chulalongkorn University 24
Testing effectiveness (Phase 2)Looking for participantsNCT06625671
What this trial is testing

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

Who this might be right for
Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus
DualityBio Inc. 148
Testing effectiveness (Phase 2)UnknownNCT00797784
What this trial is testing

The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus

Who this might be right for
Discoid Lupus Erythematosus (DLE)
Florida Academic Dermatology Centers 20
Very early researchEnrolling By InvitationNCT06661213
What this trial is testing

Tapinarof for Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus
Northwestern University 10
Testing effectiveness (Phase 2)Study completedNCT00001680
What this trial is testing

A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus

Who this might be right for
Discoid Lupus Erythematosus
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT01352988
What this trial is testing

Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Cutaneous
University Hospital Muenster 11
Large-scale testing (Phase 3)Looking for participantsNCT07355218
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Who this might be right for
Systematic Lupus ErythematosusCutaneous Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 202
Large-scale testing (Phase 3)Not Yet RecruitingNCT07691970
What this trial is testing

Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

Who this might be right for
Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus
AstraZeneca 1,072
Testing effectiveness (Phase 2)Ended earlyNCT05879718
What this trial is testing

Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

Who this might be right for
Lupus Erythematosus, SystemicLupus Erythematosus, Cutaneous
Pfizer 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07557927
What this trial is testing

A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus

Who this might be right for
Discoid Lupus Erythematosus
Kunming Pharmaceuticals, Inc. 100
Testing effectiveness (Phase 2)Study completedNCT01597050
What this trial is testing

Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions

Who this might be right for
Lupus Erythematosus, DiscoidLupus Erythematosus, Systemic
Rigel Pharmaceuticals 54
Large-scale testing (Phase 3)Study completedNCT01551069
What this trial is testing

Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion

Who this might be right for
Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Sanofi 103
Testing effectiveness (Phase 2)Study completedNCT00523588
What this trial is testing

Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser

Who this might be right for
Cutaneous Lupus Erythematosus
University of Pennsylvania 10
Testing effectiveness (Phase 2)Study completedNCT03134222
What this trial is testing

Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Cutaneous Lupus Erythematosus
Gilead Sciences 47
Not applicableLooking for participantsNCT06551389
What this trial is testing

Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU

Who this might be right for
Systemic Lupus Erythematosus
University Hospital, Brest 300
Large-scale testing (Phase 3)Enrolling By InvitationNCT06044337
What this trial is testing

A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Biogen 306
Not applicableStudy completedNCT01858792
What this trial is testing

A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies

Who this might be right for
Lupus Erythematosus, Discoid
Human Genome Sciences Inc., a GSK Company 1
Not applicableStudy completedNCT00420173
What this trial is testing

Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)

Who this might be right for
Cutaneous Lupus Erythematosus
European Society of Cutaneous Lupus Erythematosus e.V. 45
Early research (Phase 1)Study completedNCT02927457
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects

Who this might be right for
Lupus Erythematosus, Cutaneous
GlaxoSmithKline 11
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation